Header image


Drug Reimbursement & Patient Assistance Programs

ANCO's Corporate Members have provided specific information about their drug reimbursement and patient assistance programs below. For general assistance information, also visit:

American Society of Hematology




Association of Community Cancer Centers
Patient Assistance and Reimbursement Guide



Co-Payment Assistance Foundation


HealthWell Foundation

National Comprehensive Cancer Network
Reimbursement Resource Room

National Organization for Rare Disorders


Patient Advocate Foundation

Partnership for Prescription Assistance




ANCO Corporate Member
Drug Reimbursement & Patient Assistance Programs
(click on the Corporate Member Name to view a summary and links
to their Drug Reimbursement & Patient Assisitance Programs)

AbbVie • Agendia • Agios Pharmaceuticals • Alexion PharmaceuticalsAMGEN

Array BioPharma • Astellas Oncology
AstraZenecaBayer Healthcare Pharmaceuticals • bioTheranostics
Boehringer Ingelheim PharmaceuticalsBristol-Myers Squibb Oncology
Cardinal Health Specialty SolutionsCelgene • Clovis Oncology • Daiichi Sankyo

EisaiEMD Serono • Exelixis • Foundation MedicineGenentech BioOnoclogy
Genomic HealthGilead SciencesGuardant HealthHelsinn Oncology
Heron TherapeuticsIncyte
Janssen Oncology
Jazz Pharmaceuticals • Kite Pharmaceuticals • Lilly Oncology
MercknanoStringNovartis OncologyOncology Supply/International Oncology Network
Pfizer Oncology • Pfizer US BiosimilarsPharmacyclics • Puma Biotechnology
Sandoz BiopharmaceuticalsSanofi GenzymeSeattle GeneticsTaiho Oncology

Takeda Oncology • TerSera Therapeutics • TesaroTeva Oncology

Alexion Pharmaceuticals
(888) 765-4747

Back to Top


AMGEN Assist 360
(888) 4ASSIST (427-7478)
9:00AM-8:00PM Eastern Time
AMGEN Assist gives patients and healthcare professionals a single destination for access to eService and online forms, and makes it easier to find a program that would best meet each patient’s unique needs, including coverage and reimbursement services, co-pay support information, and assistance for uninsured patients. Please contact (888) 4ASSIST (888-427-7478), or visit www.amgenassist360.com.

Astellas Oncology
Cresemba Support Solutions
(800) 477-6472
Xtandi Support Solutions

(855) 898-2634
Astellas Pharma Support Solutions

All Astellas Products

Back to Top

AstraZeneca Access 360 Program
(844) 275-2360

8:00AM-8:00PM Eastern Time
Arimadex, Casodex, Faslodex, Imfinzi, Iressa, Lynparza, Tagrisso, Zoladex
AstraZeneca Access 360 provides patient access, reimbursement support, and information about affordability programs for AstraZeneca’s medicines. We help patients and providers with: Identifying and understanding prescription coverage, out-of-pocket costs, and pharmacy options; prior authorization support; pharmacy coordination; reimbursement process; claims, denials, and appeal support; connecting patients to patient savings programs; referring patients to patient assistance programs; and, connecting to nurse assistance or educational support programs, if applicable (not for all medicines).

Back to Top

Bayer Healthcare Pharmaceuticals
REACH (Patient Assistance and General Information for Nexavar and Stivarga)
(866) NEXAVAR (639-2827)
Nexavar, Stivarga
(855) 6XOFIGO (696-3446)
FAX (855) 963-4463
9:00AM-8:00PM Eastern Time
Patient assistance and general information is available for Bayer products.

Back to Top

Boehringer Ingelheim Pharmaceuticals
(877) 814-3915
8:00AM-8:00PM Eastern Time
Solutions Plus makes patient support a priority by providing a broad range of access, reimbursement, and clinical support solutions for patients who are prescribed Gilotrif tablets by helping patients quickly and affordably access Gilotrif; providing patient education; and, managing doses and adverse events to complement care. Solutions Plus improves the overall patient support experience by offering a single, dedicated specialty pharmacy (Accredo); a single point of contact; efficient and reliable service; consistent patient support; and, innovative programs to support treatment.

Bristol-Myers Squibb Oncology
BMS Access Support
(800) 861-0048
8:00AM-8:00PM Eastern Time
All Bristol-Myers Squibb Oncology Products
BMS Access Support is committed to providng access and reimbursement support, including co-pay assistance for eligible commercially-insured patients.

Back to Top

Cardinal Health Specialty Solutions
Cardinal Health e-Recovery Program
(reimbursement solution tool)
(access to all Cardinal services)
Taking advantage of patient assistance and copay assistance programs is a full-time job. Our solutions are there to help save you time and money. Community practices like yours spend a significant amount of time every day helping patients find ways to offset the rising costs of cancer care. Accessing patient assistance programs (PAPs) for cancer and supportive care drugs is important, but takes so much time. Keeping up with all the changes in program requirements and forms, tracking applications and drug replacement are an incredible burden. Layered on top of that are all the emerging copay assistance programs. The Cardinal Health e-Recovery Program provides a web-based tool to make it all so much easier. Our team has the experience to help you make sure you don't miss any opportunities to help your patients access all the available programs out there.

Back to Top

Celgene Patient Support
(800) 931-8691
5:00AM-4:00PM Pacific Time
Celgene Patient Support provides a dedicated, central point of contact for patients and healthcare professionals who use Celgene products. Celgene Patient Support is a free service that helps patients and healthcare professionals navigate the challenges of reimbursement, providing information about co-pay assistance, and answering questions about obtaining Celgene products.

Back to Top

Eisai Assistance Program

(866) 613-4724
FAX (866) 573-4724
Fragmin FAX (866) 272-8805
8:00AM-8:00PM Eastern Time
Aloxi, Halaven, Lenvima
The Eisai Assistance Program currently provides patient assistance and reimbursement support for Aloxi, Halaven, and Lenvima. A customer service representative will assist with Eisai product information, patient assistance programs for uninsured and indigent patients, underinsured patients, reimbursement questions, prior authorizations, insurance verifications, benefits investigations, referral to co-pay assistance programs, billing/coding questions, appeal assistance, and referral to disease-state assistance programs.

Back to Top

EMD Serono

(844) 8COVER1 (826-8371)
FAX (800) 214-7295
8:00AM-8:00PM Eastern Time
CoverOne provides patient access and reimbursement support services to help patients gain appropriate access to Bavencio, including reimbursement support, patient assistance support, and co-pay assistance support

Foundation Medicine

FoundationACCESS Reimbursement and Financial Assistance
(888) 988-3639
FoundationOne, FoundationOne Heme
Foundation Medicine
works within each patient’s ability to pay by providing financial assistance and payment plans through our Reimbursement and Financial Assistance Program. Foundation Medicine is committed to making the billing and reimbursement process as straightforward as possible for patients by appealing coverage decisions for Foundation Medicine’s comprehensive genomic profiling tests on behalf of patients and supporting patients every step of the way. The Financial Assistance Request Form and a video are available online. Patients may access additional information and apply for financial assistance online at https://www.foundationmedicine.com/genomic-testing#support-services.


FoundationACCESS Careline
(866) 460-1928
Monday-Thursday, 8:00AM-8:00PM Eastern Time;
Friday, 8:00AM-7:00PM Eastern Time
Foundation Medicine in collaboration with the Patient Advocate Foundation (PAF) is offering the FoundationACCESS Careline program to offer comprehensive case management services to uninsured, underinsured and insured patients who are facing obstacles obtaining prescribed targeted therapies that are approved in an indication other than the patient’s tumor type and increases physicians’ ability to act on FoundationOne or FoundationOne Heme results. Physicians may enroll their patients through the dedicated hotline or online portal.

FoundationACCESS Trial Navigator
(888) 988-3639
Foundation Medicine in collaboration with EmergingMed offers clinical trial navigation services to help patients and their physicians find and enroll in the right clinical trial for them. This service provides patients with a dedicated clinical trial navigator at EmergingMed who will work with the patient and their health care team to identify the clinical trials that best match the patient’s clinical and genomic profile and ensure successful connection to a trial site through support and follow-up. Patients or physicians can contact our client services team to learn more or enroll.

Genentech BioOncology
Genentech Access Solutions
(888) 249-4918
Alecensa, Avastin, Cotellic, Erivedge, Gazyva, Herceptin, Kadcyla, Perjeta, Rituxan, Rituxan Hycela, Tarceva, Tecentriq, Xeloda, Xeloda, Zelboraf
Genentech Access Solutions
provides one-stop access to a broad array of reimbursement information, and support and services for patients so that they can focus on treatment. In addition to providing information about co-pay assistance through independent public charities, Genentech Access Solutions can also help with common reimbursement challenges, insurance appeals and coverage denials, and referrals to the Genentech Access to Care Foundation.

(800) 443-6676
8:30AM-5:00PM Eastern Time
Kytril, Roferon-A, Vesanoid, Xeloda
offers a range of reimbursement and literature search services, including third-party payer reimbursement information, coverage and benefits verification, billing codes and claims procedures, assistance with appeals, clinical literature searches, and enrollment information for Roche’s Medical Needs Program.

Back to Top

Genomic Health
Genomic Access Program (GAP)
(866) ONCOTYPE (662-6897)
Oncotype Dx
Genomic Health has established the Genomic Access Program (GAP) to provide financial and administrative support to patients ordering the Oncotype DX assay. The GAP program was established to assist qualified patients gain access to Oncotype DX and to help patients and physicians with the entire reimbursement process. GAP is made up of dedicated professionals who advocate on a patient’s behalf by working with physicians’ offices and insurance companies to facilitate access to Oncotype DX. In addition, GAP provides various comprehensive financial assistance programs for patients with financial hardship, uninsured patients, and underinsured patients based on eligibility. While GAP directly supports the patient, it also works with physicians’ offices to provide individualized assistance and support with every claim. GAP services are available at physician or patient request, do not require pre-registration, and can be accessed at any time before, during, or after you have ordered the Oncotype DX assay. Genomic Health is prepared to bill insurance plans directly on behalf of insured patients whose physician orders an Oncotype DX assay. Through GAP, the patient’s physician can request a benefits investigation to confirm whether the patient’s insurance plan is active and obtain available benefits information specific for Oncotype DX. Some insurers require a prior authorization before processing the patient’s specimen; the GAP team can also help facilitate this process. In the event that a payer denies an Oncotype DX claim, GAP representatives will identify the reasons and advocate on the patient’s behalf. For additional information, visit www.OncotypeDX.com.

Gilead Sciences
Zydelig AccessConnect Program
(844) 6ACCESS (622-2377)
The Zydelig AccessConnect Program offers a central resource designed to help your patients access, afford, and adhere to Zydelig therapy. Patients or their providers may access the AccessConnect Program by visiting www.zydeligaccessconnect.com or www.zydelig.com or calling (844)-6ACCESS (622-2377). Our Case Specialist Team can help you navigate insurance requirements for Zydelig coverage, including determining prior authorizations and appeals requirements. Plus, they can help explain the fulfillment process of Zydelig, from the day benefits investigation starts all the way through product delivery. The Zydelig QuickStart Program offers a free 30-day supply of Zydelig for eligible patients experiencing an insurance delay of more than 5 business days. There is no purchase obligation for participation in the QuickStart Program. Patients with commercial insurance may be eligible for the Zydelig AccessConnect Copay Coupon Card. The Copay Coupon Card will cover the out-of-pocket costs for Zydelig after the first $5 per prescription fill, up to a maximum of 25% of the catalog price. Additional copay assistance may be available through independent assistance foundations that meet certain eligibility requirements, including income limits. They can help patients with government insurance, like Medicare, who are having difficulty paying for Zydelig copays, coinsurance, or other related expenses. Your patients who lack insurance coverage may be eligible to receive Zydelig free of charge through the Zydelig Patient Assistance Program. Zydelig AccessConnect understands that it may be challenging for patients to remember to take their medication. Patients who enroll in nurse support will receive the outreach where the Patient Support Nurse can support your patients with useful tips to help them take their medication as prescribed as well as provide access to patient resource groups.

Back to Top

Guardant Health
Guardant 360 Access
Guardant Health is committed to providing easy and affordable access to its test and services. Guardant Access is a program that manages the billing process for patients and is designed to reduce paperwork, manage claims appeals with insurance companies and handle most billing questions. Additional Guardant Access can be found at guardanthealth.com/wp-content/uploads/2016/06/Guardant-Access.pdf.


Back to Top


Helsinn Oncology
Helsinn Cares
84HELSINN-U (844-357-4668, Prompt 2)
FAX (844) 357-4669
Helsinn Cares is committed to providing healthcare professionals, patients, and caregivers with the resources and information needed for access and reimbursement support
. At Helsinn, one of our goals is to reduce the uncertainty of how patients will afford and access their medication. With this goal in mind, Helsinn Cares helps support patient access in 2 ways: By providing tools and resources for physicians, nurses, and office staff for reimbursement and access support for patients; and, by providing services and support for patients and caregivers that help with access, reimbursement, and patient assistance. Three programs are available for patients, one or more may be right for your patients: Pay $0 Savings Program (eligible patients with commercial insurance can pay $0 co-pay on each prescription, with an $1,800 annual limit; for patients who pay cash, the program will pay up to $150 per prescription for a maximum of $1,800 per year); Quick Start Voucher Program (for patients whose insurance company requires prior authorization for coverage of their prescription; the program provides the first dose--one tablet--for free so that the patient can start therapy while waiting for approval of their prior authorization request by the insurance company); and, Patient Assistance Program (product is available at no cost to uninsured and underinsured patients, including Medicare Part D beneficiaries, if they meet eligibility requirements).


Back to Top


Heron Therapeutics
(844) HERON11 (437-6611)
FAX (844) 504-8652
8AM-8PM Eastern Time
The SustolConnect Program is a multi-service program that can assist practices in the following areas: insurance verification; prior authorization (PA) support; appeals support; billing and coding support; co-pay assistance (non-government payers); and, drug replacement.


Back to Top


(855) 4-Jakafi (452-5234)
FAX: (855) 525-7207
5:00AM-5:00PM Pacific Time
(Connecting to Access, Reimbursement, Education and Support) provides a single point of contact through a registered nurse, OCN, to assist healthcare providers in obtaining access to Jakafi for their eligible patients and to connect those patients with continuing support and resources including: prescription insurance verification and prior authorization support; free drug and co-pay assistance, for those who qualify; referral to independent nonprofit organizations or foundations that may be able to provide financial assistance; and, access to oncology nurses. As of July 2017, IncyteCARES enrollment can now be completed online at www.IncyteCARES.com.


Back to Top


Janssen Oncology
The JanssenCarePath website provides reimbursement and patient support for over 20 Janssen products and a list of resources to assist providers and patients.

Back to Top

Jazz Pharmaceuticals
JumpStart Program
(888) 837-4397
9AM-6PM Eastern Time
Defitelio, Erwinaze
Jazz Pharmaceuticals recognizes that many patients today face financial obstacles that keep them from accessing important medications. We are committed to improving patient care through unique patient and physician programs and ongoing collaboration with patients, physicians, and advocacy groups. The JumpStart Program is sponsored by Jazz Pharmaceuticals to help improve access to Defitelio and Erwinaze for appropriate patients. This program provides reimbursement support for Defitelio and Erwinaze, including benefits investigation and access to financial assistance options for eligible patients. Additionally, we offer a patient assistance program (PAP) designed to help eligible patients gain access to Defitelio and Erwinaze. For information on the Defitelio JumpStart Program, please visit www.defitelio.com; for information on the Erwinaze JumpStart Program, please visit www.erwinaze.com.

JumpStart Program
(855) 5VYXEOS (589-9367)
9AM-8PM Eastern Time
Jazz Pharmaceuticals has reimbursement assistance available for patients being treated with Vyxeos. Dedicated JumpStart Specialists are available to assist patients starting Vyxeos in either the inpatient or outpatient setting. You can also request to be contacted by an Access and Reimbursement Manager (ARM) to assist you with additional reimbursement-related questions. Specialists can assist with investigating benefits and verifying patients’ coverage; providing information about financial assistance programs for eligible patients; providing prior authorization and appeals support (outpatient setting); answering coding and other reimbursement questions.


Back to Top

Lilly Oncology
Lilly PatientOne

(866) 4PatOne (472-8663)
9:00A-7:00PM Eastern Time
Alimta, Cyramza, Gemzar
Lilly Oncology’s PatientOne strives to offer reliable and individualized treatment support for eligible patients prescribed a Lilly Oncology product whether they are insured, underinsured, or simply uninsured. For those who qualify, Lilly PatientOne can help in the following ways: connect patients with the Patient Assistance Program to determine eligibility and funding options; evaluate financial assistance options including co-pay programs and co-pay assistance foundations; provide reimbursement assistance (benefits investigations, prior authorization, evaluation of other funding options); and, assist with denied claim appeals. Lilly Oncology's co-pay assistance program has transitioned to a non-needs based program eliminating the income requirements for participation and has extended the look back period from 30 to 120 days.

The Merck AccessProgram
(855) 257-3932
8:00AM-8:00PM Eastern Time
The Merck Access Program
can help answer questions about access and support, including insurance coverage for patients, reimbursement, benefit investigations, prior authorizations, appeals, and referrals to the Merck Patient Assistance Program.

Prosigna Patient Support Program (PPSP)
Prosigna Prognostic Breast Cancer Gene Signature
The Prosigna Patient Support Program (PPSP) is designed to help breast cancer patients gain access to the important information which can be obtained from the Prosigna Prognostic Breast Cancer Gene Signature. The Program includes an array of services to meet the needs of patients and health care providers.

Novartis Oncology
Oncology Access Now
Reimbursement Hotline
(800) 282-7630
Patient Assistance Programs
(866) 884-5906
Novartis is committed to providing access to its medicines for those most in need. Through a variety of resources, including the Novartis Oncology Patient Assistance Program, the Novartis Oncology Reimbursement Hotline, and our support of independent charitable copay foundations, Novartis has made a firm commitment to enable patients in need to access medicines. Visit www.oncologyaccessnow.com for complete patient assistance, reimbursement, and clinical trial information.

Back to Top

Oncology Supply/ION
(888) 536-7697
For over 35 years, Oncology Supply has distributed chemotherapy and supportive care products to independent oncology practices nationwide from our office/distribution center in Dothan, Alabama Our passion is customer satisfaction. Our priority is exceeding expectations by delivering friendly, responsive service, while making the purchasing process easy and reliable to help our practices positively impact cancer patients’ lives. Creating relationships of trust and loyalty is the foundation of our culture. Our experience and stability in the marketplace allows us to understand our customer challenges and achieve timely resolution with transparency. We guarantee the integrity of the origin of all pharmaceutical products we sell. In 1998, we partnered as the exclusive distributor for ION Solutions. Community-based oncologists rely on ION Solutions for creative GPO contracting, integrated dispensing solutions, and the expertise practices need to improve clinical and operational management. Pharmaceutical manufacturers rely on us as a trusted preferred partner for achieving product exposure and driving growth with existing products. Managed care companies depend on us to develop innovative programs to reduce overall costs and variability of care among our practices. With our extensive industry network experience, we have the knowledge, consulting guidance, and contracting programs to help oncology practices succeed. ION Solutions introduced the Community Counts advocacy campaign in 2012. Through this, practices are encouraged to take charge and enact change to shape healthcare delivery.

Back to Top

Pfizer Oncology
(877) 744-5675
FAX (877) 736-6506
9:00AM-8:00PM Eastern Time
Aromasin, Bosulif, Camptosar, Ellence, Emcyt, Ibrance, Idamycin, Inlyta, Neumega, Sutent, Torisel, Xalkori, Zinecard
Pfizer Oncology is committed to helping patients get access to the medications they need. Pfizer Oncology Together has a range of offerings to provide eligible patients with financial support, regardless of their insurance coverage, including: Uninsured—patients who do not have any form of healthcare coverage; Commercially insured—commercial, private, employer, and healthcare exchange patients; Medicare/Government insured—Medicare, Medicaid, and other government insured patients; one-to-personalized office support and education to help offices best navigate access and reimbursement issues. Please reach out to your Pfizer representative for additional details.

Back to Top


Pfizer US Biosimilars
Pfizer enCompass
(844) 722-6672
FAX (844) 482-4482
9:00AM-8:00PM Eastern Time
Pfizer enCompass is your comprehensive resource for information and resources related to reimbursement and patient access for Inflectra. With Pfizer enCompass, you have access to a team of experienced Access Counselors trained to investigate your patients’ insurance benefits and coverage details for Inflectra. Access Counselors can also help your office navigate prior authorization requirements, coding and billing questions, the appeals process, and identify affordability options to help appropriate patients get started with Inflectra treatment. Pfizer enCompass provide a variety of patient support programs to help patients access Inflectra therapy including assistance for eligible uninsured and insured patients who cannot afford their out-of-pocket costs..

Back to Top

YOU&i Support Program
(877) 877-3536
YOU&i Support Program is a personalized support program from Pharmacyclics and Janssen Oncology that includes information on access and affordability, nurse call support, and resources for patients being treated with Imbruvica. Patients or their provider may access the YOU&I Support Program by visiting www.youandiaccess.com or www.imbruvica.com or calling (877) 877-3536. YOU&i Support Program provides rapid (within 2 business days) benefit investigation, information about the prior authorization process, information about the insurance appeals process and can refer you to a specialty pharmacy. Patients may qualify for YOU&i Start: (If a patient is experiencing an insurance coverage decision delay, this program may give you access to Imbruvica.) Patients may also qualify for YOU&i Instant Savings Program: (If a patient has commercial health insurance and meets eligibility requirements, they will pay no more than $10 per month for Imbruvica.).

Sandoz Biopharmaceuticals
Sandoz One Source
(844) SANDOZ1 (726-3691)
FAX (844) SANDOZ5 (726-3695)
9:00AM-8:00PM Eastern Time

Sanofi Genzyme
Sanofi Patient Connection
Provider Portal for Healthcare Professionals
Information Website for Patients and Providers
(888) visitSPC (847-4877)
FAX (888) 847-1797
9:00AM-8:00PM Eastern Time
As part of Sanofi Genzyme's commitment to comprehensive disease management we offer resources to help healthcare professionals provide care for their patients. Sanofi Patient Connection is a program that includes patient assistance and reimbursement services to help take the challenge out of gaining access to Sanofi products for patients in need. Visit the Sanofi Patient Connection website for additional information or call (888) visitSPC.

Back to Top

Seattle Genetics
SeaGen Secure Services
(855) 473-2973
9:00AM-8:00PM Eastern Time
SeaGen Secure is a comprehensive reimbursement support hotline and patient assistance program for Adcetris. Reimbursement counselors are available to provide coverage, coding and reimbursement information in addition to case management for our patient assistance programs. Patient assistance is available to uninsured and underinsured patients that have been prescribed Adcetris. Eligibility for patient assistance is based on gross family household income, residency and diagnosis. Additional program services include benefit investigations, assistance with underpaid/denied claims, Adcetris policy information and alternate funding research. Patients now have access to an Oncology Nurse Advocate when the call (855) 4SECURE. Our Oncology Nurse Advocate can assist patients with access to advocacy associations as well as provide regular patient support emails and newsletters.


Back to Top

Taiho Oncology
Taiho Oncology Patient Support
(844) TAIHO-4U 824-4648)
FAX (844) 287-2559
Taiho Oncology Patient Support provides financial support (insurance coverage and reimbursment support, co-pay savings for commercially insured patients, alternate funding support for Medicaid/Medicare- or government-insured patients, and patient assitance for those unable to afford Longsurf), and personalized nurse support.

Back to Top


Takeda Oncology
Takeda Oncology 1Point
One point of connection for access and support

Alumbirg 1Point

(844) A1POINT (217-6468)
8AM-8PM Eastern Time

The Alumbirg 1Point dedicated case management team can deliver personalized services that help patients and providers navigate coverage requirements for Alunbrig, steamline product access, and connect to helpful resources. Services include benefit verification and prior authorization assistance; assistance with appealing a payer denial; Alunbrig Co-Pay Assistance Program enrollment for eligible, commercially insured patients; specialty pharmacy referral and coordination; referral to alternative funding sources and third-party foundations; connection to support services, including referrals for legal services and national and local organizations for counseling; and, Patient Assistance Program.

Iclusig 1Point

(844) T1POINT (817-6468)
8AM-8PM Eastern Time

Ninlaro 1Point

(844) N1POINT (817-6468)
8AM-8PM Eastern Time

Velcade Reimbursement Assistance Program (VRAP)
(866) VELCADE, Option #2
5:00AM-5:00PM Pacific Time
Takeda Oncology
has developed this reimbursement resource website as a tool to help physicians understand the healthcare insurance environment for Velcade. While payers generally reimburse for Velcade, it is the details that dictate coverage for each individual patient’s healthcare. This website provides general guidance regarding steps to support appropriate reimbursement and patient access to Velcade treatment. The VRAP line can also assist with benefit investigation and transportation assistance.

Back to Top

Together with Tesaro
(844) 2TESARO (283-7276)
8:00AM-8:00PM Eastern Time
Together with Tesaro provides a co-pay assistance program (virtual pay card), a patient assistance program, the First Dose Program, and coverage support.

Teva Oncology
CORE (Comprehensive Oncology Reimbursement Expertise)
(888) 587-3263
FAX (866) 676-4073
9:00AM-7:00PM Eastern Time
CORE provides support for branded Teva Oncology products. Teva Oncology support programs are designed to help patients and healthcare providers navigate the reimbursement landscape with resources aimed at clarifying issues and assisting with the claims process. Specific assistance includes benefit verification and coverage determination, policy benefits and limitations, personalized support through the claims process, and appeals support.